Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
J. David Joyner is President and CEO at CVS Health. OQRO lists 3 transactions filed with the SEC under this name, the latest on Apr 2, 2026, each linked to the official Form 4.
President and CEO
Disclosures on record
3
Companies involved
1
CVS HealthCVS
3 disclosures · Mar 2026 – Apr 2026
Mar 31, 202686Kdisclosed Apr 2
DetailsOfficial recordApr 1, 20268,029disclosed Apr 2
DetailsOfficial recordFeb 28, 20261,944disclosed Mar 2
DetailsOfficial recordJ. David Joyner has no open-market purchase on record since 2012. Sales in 2 of the 15 years since 2012.
J. David Joyner reported 0 open-market purchases and 8 sales since 2012; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2014 | — | $24.9M4×4 trades |
| 2012 | — | $4.42M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , J. David Joyner reported holding 70,349 shares of CVS Health (CVS), worth about $5.72M at the last close of $81 (Nov 18, 2026).
CVS Health's proxy statement reports total compensation of $21.2M for J. David Joyner for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 3, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| CVS Health CVS | 70,349 | 70K direct | $81 | $5.72M | Apr 1, 2026 |
Is this J. David Joyner’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
J. David Joyner reported 0 open-market purchases and 8 sales here, 2012 to 2014.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Apr 1, 2026, J. David Joyner reported holding 70,349 shares of CVS Health (CVS). At the last close of $81 on Nov 18, 2026, that is about $5.72M. This is the stake disclosed in filings, not a net worth.
No public filing gives J. David Joyner's net worth. What SEC Form 4 shows is the stock stake: 70,349 shares of CVS Health (CVS), about $5.72M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
CVS Health's proxy statement reports total compensation of $21.2M for J. David Joyner for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
J. David Joyner has no open-market purchase on record since 2012. Sales in 2 of the 15 years since 2012.
In SEC filings since 2012: no open-market purchase is on record; the latest open-market sale is from 2014.
CVS Health (CVS), from 2012 to 2014: 0 purchases and 8 sales.